What a pharmacokinetics viva is testing

Pharmacokinetics viva questions ask you to explain what the body does to a drug, use the relevant model, and interpret what the calculation means. A sound answer does more than recite an equation: it states the assumptions, keeps the units visible, and connects the result to a decision or limitation.

There is no single international pharmacokinetics viva format. Your course or assessment may emphasise different topics and timings, so check your syllabus and the relevant institution’s official guidance for its structure and criteria. The practice stations below are teaching examples, not a description of a particular exam.

A useful answer sequence is:

  1. Name the concept or equation. For example, loading dose equals target concentration multiplied by volume of distribution, adjusted for bioavailability when the route is not intravenous.
  2. State the assumptions. Say whether the model assumes linear, first-order elimination or a particular bioavailability.
  3. Work with units. Show how units cancel rather than jumping straight to a number.
  4. Interpret the result. Explain what it means for concentration, timing or monitoring.
  5. Name a limitation or safety check. A calculated dose is not automatically a suitable prescribed dose.

A practice examiner persona in MySummaries can keep those habits in view without pretending to represent a specific university or registration exam:

ExaminerPharmacokinetics viva practice
State the model and assumptionsShow the calculation with unitsInterpret the result and identify limitations

Build stations from core pharmacokinetic decisions

A useful practice station is built around a decision, not just a definition. Include the information needed to reason through it, then practise explaining the answer aloud in a clear order. Start with common calculations—loading dose, maintenance dosing and half-life—before moving to concentration monitoring, altered clearance and nonlinear elimination.

Keep the prompt focused. A candidate should be able to identify what is being asked, explain the calculation, and say what additional information might change the interpretation. Avoid adding details that create a different clinical question from the one you intend to practise.

A set of stations on these topics might look like this in MySummaries:

StationAttemptsBestAvg
Loading dose and routeA 70 kg adult has an estimated Vd of 0.6 L/kg. For a hypothetical target concentration of 10 mg/L, calculate an IV loading dose, then explain how the calculation changes if oral bioavailability is 0.70.37872
Half-life and infusionA drug has a Vd of 42 L and clearance of 3.5 L/h. Calculate its half-life and estimate the time to approach steady state during a constant infusion.27671
Nonlinear phenytoin kineticsA patient’s phenytoin concentration rises more than expected after a modest dose increase. Explain the pharmacokinetic reason and how you would approach interpretation and monitoring.0——
Maintenance doseFor a hypothetical oral drug, target Css is 10 mg/L, clearance is 3 L/h, F is 0.75 and the interval is 8 hours. Estimate the dose per interval and state the assumptions.17474
Changing clearanceA patient’s renal function has changed while they are taking a renally eliminated drug. Explain which pharmacokinetic quantities may change and what further information is needed before adjusting a regimen.0——

Station 1: Loading dose and route

This station tests whether you can distinguish loading from maintenance dosing. A loading dose is used to reach a target concentration more quickly; it depends on the target concentration and volume of distribution, rather than on clearance. For an oral route, account for bioavailability in the calculation.

The values below are deliberately specified as a hypothetical pharmacokinetic exercise. They are not a dosing recommendation for a real medicine or patient. Speak through the arithmetic and then state why a calculated value still needs clinical checking.

Oral — Loading dose and routeMarked

Examiner

A 70 kg adult has an estimated Vd of 0.6 L/kg. For a hypothetical target concentration of 10 mg/L, calculate an IV loading dose, then explain how the calculation changes if oral bioavailability is 0.70.

2:323:00Mark answer
78%Loading dose and route — marked78/100 · Good progress · 2:32 spoken of 3:00
Selects the loading-dose relationship and states assumptions17/20

You used target concentration multiplied by volume of distribution and treated the supplied values as applicable to the hypothetical case.

ImproveSay explicitly that the calculation assumes the target and Vd are appropriate for the patient and drug.

Calculates accurately and uses units16/20

You calculated Vd as 42 L and the IV amount as 420 mg.

ImproveShow the cancellation: 10 mg/L × 42 L = 420 mg.

Accounts for route and bioavailability15/20

You recognised that an oral dose must be adjusted for F, but the final amount was not stated clearly.

ImproveFor F = 0.70, 420 mg ÷ 0.70 = 600 mg as the modelled oral amount.

Interprets the result and notes a limitation14/20

You noted that the result is theoretical but did not identify what must be checked before applying it.

ImproveMention formulation, tolerability, the chosen target concentration and patient-specific factors; do not present this exercise as a prescription.

A strong answerFirst I calculate the volume of distribution: 0.6 L/kg multiplied by 70 kg gives 42 L. The IV loading dose is target concentration multiplied by Vd, so 10 mg/L multiplied by 42 L gives 420 mg. For the oral route, assuming F is 0.70, divide 420 mg by 0.70 to obtain a modelled amount of 600 mg. This calculation assumes the stated target, Vd and bioavailability are suitable; a real dose also needs checking against the drug, formulation and patient.

That is a MySummaries station, filled with pharmacokinetics material. Yours is written from your own notes. Start free

Notice the order in the model answer: quantity, equation, units, result, route adjustment, then limitation. Practise keeping that order even when the numbers are simple. If you lose your place, return to the units: mg/L multiplied by L gives mg.

Station 2: Half-life and time to steady state

This station joins two ideas that are often tested separately. Under a first-order model, half-life is calculated from volume of distribution and clearance. During a constant infusion, the time to approach steady state depends on half-life—not on the infusion rate. The rate determines the eventual concentration; the half-life determines how quickly it is approached.

For the supplied values, the calculation is 0.693 × 42 L ÷ 3.5 L/h, giving approximately 8.3 hours. A common approximation is that steady state is approached after about four to five half-lives, or roughly 33–42 hours here. This is an approximation, not a sharp point at which the concentration suddenly becomes steady.

Oral — Half-life and infusionMarked

Examiner

A drug has a Vd of 42 L and clearance of 3.5 L/h. Calculate its half-life and estimate the time to approach steady state during a constant infusion. If the target steady-state concentration is 10 mg/L, what infusion rate would the simple model imply?

2:413:00Mark answer
76%Half-life and infusion — marked76/100 · Good progress · 2:41 spoken of 3:00
Chooses the correct half-life equation16/20

You used 0.693 × Vd divided by clearance.

ImproveState that this relation assumes first-order elimination and consistent units.

Completes the calculation with units15/20

Your estimate of about 8.3 hours was correct, though the unit conversion was not spoken through.

ImproveWrite 0.693 × 42 L ÷ 3.5 L/h; the result is in hours.

Explains approach to steady state14/20

You gave a reasonable approximate time but made it sound like a precise endpoint.

ImproveDescribe four to five half-lives as an approximation to steady state, not an exact threshold.

Separates infusion rate from time to steady state16/20

You correctly linked the target concentration to clearance when discussing infusion rate.

ImproveFor this simplified example, say rate = Css × CL = 10 mg/L × 3.5 L/h = 35 mg/h, while half-life governs the approach time.

A strong answerFor first-order elimination, half-life is 0.693 multiplied by Vd and divided by clearance. Substituting 42 L and 3.5 L/h gives about 8.3 hours. Four to five half-lives is a useful approximation for approaching steady state, so that is roughly 33 to 42 hours. If the target Css is 10 mg/L, the simple infusion-rate calculation is Css multiplied by clearance, or 35 mg/h. The infusion rate sets the modelled eventual concentration, whereas the half-life determines how quickly it is approached.

The most useful correction here is to keep the two questions separate: “How long?” is about half-life; “What rate?” is about clearance multiplied by the target steady-state concentration. In an oral answer, stating that distinction often makes your reasoning easier to follow than listing equations without context.

Station 3: Nonlinear phenytoin kinetics

A viva may move from arithmetic to explaining an unexpected concentration change. Phenytoin is a useful example because its metabolism can become saturated over the therapeutic concentration range. With capacity-limited elimination, a small dose increase may produce a disproportionately large increase in concentration. The simple proportional relationship between dose and concentration that works under linear pharmacokinetics cannot safely be assumed near saturation.

You do not need to invent a dose adjustment to give a good answer. Explain the mechanism, check whether the result can be interpreted, and describe how concentration monitoring and the clinical picture inform the next step. Total phenytoin concentration can also be misleading when protein binding is altered; a free concentration may be relevant in situations such as hypoalbuminaemia or renal impairment, interpreted using local practice and laboratory guidance.

Oral — Nonlinear phenytoin kineticsMarked

Examiner

A patient’s phenytoin concentration rises more than expected after a modest dose increase. Explain the pharmacokinetic reason and how you would approach interpretation and monitoring.

2:483:00Mark answer
78%Nonlinear phenytoin kinetics — marked78/100 · Good progress · 2:48 spoken of 3:00
Explains capacity-limited metabolism17/20

You identified saturable metabolism as the reason concentration may rise disproportionately.

ImproveName the Michaelis–Menten relationship and contrast it with proportional first-order elimination.

Links mechanism to the dose–concentration change15/20

You explained the direction of change but did not make the implication for dose adjustment explicit.

ImproveSay that near metabolic capacity, a modest dose increase can cause a relatively large concentration rise.

Considers factors affecting concentration interpretation15/20

You mentioned adherence and interactions, but left protein binding out of the answer.

ImproveCheck sampling context, interacting medicines and albumin or renal status; consider whether a free level is appropriate.

Describes cautious monitoring and clinical review15/20

You proposed monitoring but did not connect the result with symptoms and a safe review plan.

ImproveRelate the concentration to the clinical picture and seek appropriate prescriber or specialist review rather than suggesting an automatic dose change.

A strong answerPhenytoin can show capacity-limited, or Michaelis–Menten, metabolism. As the metabolic pathway approaches saturation, elimination is no longer simply proportional to concentration, so a modest dose increase may cause a disproportionately large rise in concentration. I would check the timing and context of the sample, adherence and interacting medicines, and consider protein binding if albumin is low or renal function is impaired. I would interpret the result alongside the patient’s clinical state and local monitoring guidance. I would not recommend an automatic dose increase or decrease from one concentration alone.

The station rewards mechanism and judgement together. Saying “nonlinear” is only the start; the examiner needs to hear what that changes about dose–concentration prediction. Equally, an impressive equation does not replace checking whether the measured total concentration reflects the pharmacologically relevant exposure in that patient.

A transcript review in MySummaries can isolate one phrase that cost a mark and replace it with a more complete version:

Transcript

Phenytoin has nonlinear kinetics because its metabolism can become saturated. A small increase can make the level go up. I would check the sample and consider adherence or interactions. Then I would change the dose based on the number.

not enough detail
A small increase can make the level go up.

The direction is right, but it does not explain why the concentration change may be disproportionate near metabolic saturation.

Say: Say: ‘As metabolism approaches capacity, a modest dose increase may cause a disproportionately large rise in concentration, so I would adjust cautiously using the clinical picture and monitoring guidance.’

How to practise these questions

Use a short, repeatable routine rather than trying to memorise a polished speech. First, answer the opening question aloud without reading a model. Give yourself time to name the concept, state assumptions and finish the calculation. Then compare your explanation with the model and identify one specific omission: a unit, the route adjustment, a limitation, or the clinical interpretation.

On the next attempt, fix that omission—not every sentence. A useful self-check after each response is:

  • Did I answer the question asked before adding related facts?
  • Did I name the equation or mechanism?
  • Were the units and arithmetic explicit?
  • Did I explain what the result means?
  • Did I state one relevant limitation or safety check?

For calculation stations, practise aloud with fresh values so you learn the method rather than one answer. For conceptual stations, use a case-change prompt: what would you ask next if the concentration were unexpected, clearance changed, or protein binding were altered? Keep drug-specific decisions within your course material and local guidance; general pharmacokinetic relationships do not replace prescribing information.

How MySummaries helps

Build a revision board from your own lecture notes, slides or annotated PDFs, then practise spoken answers against the material you are studying. MySummaries can mark a recorded viva-style response, show where an explanation lost detail and turn repeated gaps into revision prompts. Use the feedback as a study aid, and check your course’s official guidance for the assessment’s actual format and criteria. Open MySummaries.